BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Trials

Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics

Lycia is using its proprietary lysosomal targeting chimeras (LYTACs) platform to discover and develop first-in-class therapeutics that degrade extracellula...

December 05, 2023 | News

Insilico Medicine Launches First Human Study for ISM5411, Oral PHD Inhibitor for IBD

ISM5411 is an oral, PHD-specific inhibitor that facilitates the treatment of IBD by inducing the expression of gut barrier protective genes. ISM5411 is ...

December 05, 2023 | News

Clarivate and VeriSIM Life Strengthen Collaboration for Efficient Drug Development

Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, ...

December 05, 2023 | News

Alecensa by Roche Cuts Risk in Asian ALK-Positive Lung Cancer Patients by Over 60%.

ALINA is the first and only Phase III study to show an improvement in disease-free survival in patients from Asia with early-stage resected ALK-posit...

December 04, 2023 | News

AWS and Accenture Aid Merck in Cloud-Powered Drug Discovery and Clinical Trial Acceleration

At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced it is working with Accenture (NYSE: ACN...

November 30, 2023 | News

Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort

Cohort 3 of the theranostic SECuRE trial investigating 64Cu/67Cu-SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has enrolled a...

November 30, 2023 | News

AbbVie Provides FDA and EMA Updates on Epcoritamab for Lymphoma Treatment

Updates are supported by data from the Phase 1/2 EPCORE™ NHL-1 clinical trial AbbVie announced updates from the U...

November 29, 2023 | News

Everest Medicines Gets NMPA Approval for Nefecon® in China for IgA Nephropathy

--Nefecon® is the first approved medicine with an IgAN indication in China-- --The approval marks a new era of IgAN treatment for Chinese patient...

November 27, 2023 | News

DxVx Plans License-In of OVM-200, Launches Clinical Trials in Asia

Final stage in licensing OVM-200 from Oxford Vacmedix in the UK- DxVx plans to proceed its own clinical trials in Asia, including Korea and Chi...

November 27, 2023 | News

Simcere and Connect ink exclusive deal for autoimmune drug Rademikibart.

Pursuant to the Agreement, Simcere obtains the exclusive rights in the development, manufacturing, and commercialization of Rademikibart for all indication...

November 24, 2023 | News

BeiGene and Ensem Therapeutics Partner to Advance CDK2 Inhibitor

“We are committed to developing novel molecules with the potential to transform the therapeutic landscape for cancer patients, and this partnership f...

November 23, 2023 | News

Senhwa Biosciences Granted FDA IND for Phase II Study of Silmitasertib in Viral Community-Acquired Pneumonia (CAP)

The trial is a phase II multi-center, randomized-controlled interventional prospective study, and the purpose of this trial is to investigate whether ...

November 22, 2023 | News

Micron Biomedical Secures $23.6M to Advance Needle-Free Vaccine Production for Measles Eradication

Micron has received this grant from the Bill & Melinda Gates Foundation to fund mass production of needle-free vaccines utilizing Micron technology t...

November 20, 2023 | News

Clinical trial expands evidence base for the Wobenzym® brand

A recent clinic trial is expanding the evidence base for the Wobenzym® brand. The results are published in Therapeutic Advances in Musculoske...

November 19, 2023 | News

Stay Connected